NCT01007929View on ClinicalTrials.gov

Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

October 31, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy

Interventions

DRUG

14C-AZD1236

Oral solution 1mg/mL

Trial Locations (1)

Unknown

Research Site, Macclesfield

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT01007929 - Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter